Table 3 Prevalence and severity of potential drug-drug interactions among the study participants
Variables | Category | Frequency, n (%) | Median (range) |
|---|---|---|---|
Prevalence of pDDIs | 1–3 | 107(33%) | 3 (1–7) |
4–5 | 84(25.8%) | ||
≥ 6 | 33(10.2%) | ||
Total | 224 (68.9%) | ||
Level (severity) of pDDIs | Serious | 52(23.2%) | |
Significant | 172(76.8%) |